DDB1- and CUL4-associated factor 15 isoform 1 [Mus musculus]
Protein Classification
List of domain hits
| Name | Accession | Description | Interval | E-value | |||||
| DCAF15_WD40 | pfam14939 | DDB1-and CUL4-substrate receptor 15, WD repeat; DCAFs, Ddb1- and Cul4-associated factors, are ... |
48-259 | 6.95e-118 | |||||
DDB1-and CUL4-substrate receptor 15, WD repeat; DCAFs, Ddb1- and Cul4-associated factors, are substrate receptors for the Cul4-Ddb1 Ubiquitin Ligase. There are 18 different factors, the majority of which are WD40-repeat-proteins. : Pssm-ID: 464387 Cd Length: 206 Bit Score: 349.71 E-value: 6.95e-118
|
|||||||||
| DCAF15-CTD | cd20913 | C-terminal domain of DDB1- and CUL4-associated factor 15; This model represents the C-terminal ... |
387-637 | 1.96e-69 | |||||
C-terminal domain of DDB1- and CUL4-associated factor 15; This model represents the C-terminal domain of DCAF15 (DDB1- and CUL4-associated factor 15), the cullin RING ligase substrate receptor/adaptor that forms a complex with CUL4A or CUL4B, as part of the Rbx-Cul4-DDA1-DDB1-DCAF15 E3 ubiquitin ligase that is responsible for the proteasome degradation of certain proteins. Aryl sulfonamide anticancer agents such as indisulam, tasisulam, E7820, and chloroquinoxaline have been shown to recruit the essential mRNA-splicing factor RBM39 to DCAF15. These agents appear to promote binding of DCAF15 to the RNA-recognition motif (RRM) of RBM39, which suggests that derivatives of the aryl-sulfonamides may be used to target other RRM-containing proteins. Cell proliferation is inhibited by these aryl sulfonamides by causing degradation of RBM39, which leads to aberrant processing of pre-mRNA in hundreds of genes, primarily reflected by intron retention and exon skipping, thus collectively referred to as splicing inhibitor sulfonamides, or SPLAMs. : Pssm-ID: 411023 Cd Length: 224 Bit Score: 224.86 E-value: 1.96e-69
|
|||||||||
| Name | Accession | Description | Interval | E-value | |||||
| DCAF15_WD40 | pfam14939 | DDB1-and CUL4-substrate receptor 15, WD repeat; DCAFs, Ddb1- and Cul4-associated factors, are ... |
48-259 | 6.95e-118 | |||||
DDB1-and CUL4-substrate receptor 15, WD repeat; DCAFs, Ddb1- and Cul4-associated factors, are substrate receptors for the Cul4-Ddb1 Ubiquitin Ligase. There are 18 different factors, the majority of which are WD40-repeat-proteins. Pssm-ID: 464387 Cd Length: 206 Bit Score: 349.71 E-value: 6.95e-118
|
|||||||||
| DCAF15-NTD | cd20917 | N-terminal domain of DDB1- and CUL4-associated factor 15; This model represents the N-terminal ... |
35-259 | 6.53e-94 | |||||
N-terminal domain of DDB1- and CUL4-associated factor 15; This model represents the N-terminal domain of DCAF15 (DDB1- and CUL4-associated factor 15), the cullin RING ligase substrate receptor/adaptor that forms a complex with CUL4A or CUL4B, as part of the Rbx-Cul4-DDA1-DDB1-DCAF15 E3 ubiquitin ligase that is responsible for the proteasome degradation of certain proteins. Aryl sulfonamide anticancer agents such as indisulam, tasisulam, E7820, and chloroquinoxaline have been shown to recruit the essential mRNA-splicing factor RBM39 to DCAF15. These agents appear to promote binding of DCAF15 to the RNA-recognition motif (RRM) of RBM39, which suggests that derivatives of the aryl-sulfonamides may be used to target other RRM-containing proteins. Cell proliferation is inhibited by these aryl sulfonamides by causing degradation of RBM39, which leads to aberrant processing of pre-mRNA in hundreds of genes, primarily reflected by intron retention and exon skipping, thus collectively referred to as splicing inhibitor sulfonamides, or SPLAMs. Pssm-ID: 411024 Cd Length: 225 Bit Score: 288.45 E-value: 6.53e-94
|
|||||||||
| DCAF15-CTD | cd20913 | C-terminal domain of DDB1- and CUL4-associated factor 15; This model represents the C-terminal ... |
387-637 | 1.96e-69 | |||||
C-terminal domain of DDB1- and CUL4-associated factor 15; This model represents the C-terminal domain of DCAF15 (DDB1- and CUL4-associated factor 15), the cullin RING ligase substrate receptor/adaptor that forms a complex with CUL4A or CUL4B, as part of the Rbx-Cul4-DDA1-DDB1-DCAF15 E3 ubiquitin ligase that is responsible for the proteasome degradation of certain proteins. Aryl sulfonamide anticancer agents such as indisulam, tasisulam, E7820, and chloroquinoxaline have been shown to recruit the essential mRNA-splicing factor RBM39 to DCAF15. These agents appear to promote binding of DCAF15 to the RNA-recognition motif (RRM) of RBM39, which suggests that derivatives of the aryl-sulfonamides may be used to target other RRM-containing proteins. Cell proliferation is inhibited by these aryl sulfonamides by causing degradation of RBM39, which leads to aberrant processing of pre-mRNA in hundreds of genes, primarily reflected by intron retention and exon skipping, thus collectively referred to as splicing inhibitor sulfonamides, or SPLAMs. Pssm-ID: 411023 Cd Length: 224 Bit Score: 224.86 E-value: 1.96e-69
|
|||||||||
| Name | Accession | Description | Interval | E-value | |||||
| DCAF15_WD40 | pfam14939 | DDB1-and CUL4-substrate receptor 15, WD repeat; DCAFs, Ddb1- and Cul4-associated factors, are ... |
48-259 | 6.95e-118 | |||||
DDB1-and CUL4-substrate receptor 15, WD repeat; DCAFs, Ddb1- and Cul4-associated factors, are substrate receptors for the Cul4-Ddb1 Ubiquitin Ligase. There are 18 different factors, the majority of which are WD40-repeat-proteins. Pssm-ID: 464387 Cd Length: 206 Bit Score: 349.71 E-value: 6.95e-118
|
|||||||||
| DCAF15-NTD | cd20917 | N-terminal domain of DDB1- and CUL4-associated factor 15; This model represents the N-terminal ... |
35-259 | 6.53e-94 | |||||
N-terminal domain of DDB1- and CUL4-associated factor 15; This model represents the N-terminal domain of DCAF15 (DDB1- and CUL4-associated factor 15), the cullin RING ligase substrate receptor/adaptor that forms a complex with CUL4A or CUL4B, as part of the Rbx-Cul4-DDA1-DDB1-DCAF15 E3 ubiquitin ligase that is responsible for the proteasome degradation of certain proteins. Aryl sulfonamide anticancer agents such as indisulam, tasisulam, E7820, and chloroquinoxaline have been shown to recruit the essential mRNA-splicing factor RBM39 to DCAF15. These agents appear to promote binding of DCAF15 to the RNA-recognition motif (RRM) of RBM39, which suggests that derivatives of the aryl-sulfonamides may be used to target other RRM-containing proteins. Cell proliferation is inhibited by these aryl sulfonamides by causing degradation of RBM39, which leads to aberrant processing of pre-mRNA in hundreds of genes, primarily reflected by intron retention and exon skipping, thus collectively referred to as splicing inhibitor sulfonamides, or SPLAMs. Pssm-ID: 411024 Cd Length: 225 Bit Score: 288.45 E-value: 6.53e-94
|
|||||||||
| DCAF15-CTD | cd20913 | C-terminal domain of DDB1- and CUL4-associated factor 15; This model represents the C-terminal ... |
387-637 | 1.96e-69 | |||||
C-terminal domain of DDB1- and CUL4-associated factor 15; This model represents the C-terminal domain of DCAF15 (DDB1- and CUL4-associated factor 15), the cullin RING ligase substrate receptor/adaptor that forms a complex with CUL4A or CUL4B, as part of the Rbx-Cul4-DDA1-DDB1-DCAF15 E3 ubiquitin ligase that is responsible for the proteasome degradation of certain proteins. Aryl sulfonamide anticancer agents such as indisulam, tasisulam, E7820, and chloroquinoxaline have been shown to recruit the essential mRNA-splicing factor RBM39 to DCAF15. These agents appear to promote binding of DCAF15 to the RNA-recognition motif (RRM) of RBM39, which suggests that derivatives of the aryl-sulfonamides may be used to target other RRM-containing proteins. Cell proliferation is inhibited by these aryl sulfonamides by causing degradation of RBM39, which leads to aberrant processing of pre-mRNA in hundreds of genes, primarily reflected by intron retention and exon skipping, thus collectively referred to as splicing inhibitor sulfonamides, or SPLAMs. Pssm-ID: 411023 Cd Length: 224 Bit Score: 224.86 E-value: 1.96e-69
|
|||||||||
| Blast search parameters | ||||
|
